
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Base editing screens map mutations affecting interferon-γ signaling in cancer
Matthew A. Coelho, Sarah Cooper, Magdalena E. Strauß, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 288-303.e6
Open Access | Times Cited: 54
Matthew A. Coelho, Sarah Cooper, Magdalena E. Strauß, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 288-303.e6
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 250
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 250
Precise genome-editing in human diseases: mechanisms, strategies and applications
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 17
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 17
Base-editing mutagenesis maps alleles to tune human T cell functions
Ralf Schmidt, Carl C. Ward, Rama Dajani, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 805-812
Open Access | Times Cited: 37
Ralf Schmidt, Carl C. Ward, Rama Dajani, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 805-812
Open Access | Times Cited: 37
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
Gabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1457-1475
Closed Access | Times Cited: 16
Gabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1457-1475
Closed Access | Times Cited: 16
Joint genotypic and phenotypic outcome modeling improves base editing variant effect quantification
Jayoung Ryu, Sam Barkal, Tian Yu, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 925-937
Closed Access | Times Cited: 10
Jayoung Ryu, Sam Barkal, Tian Yu, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 925-937
Closed Access | Times Cited: 10
Harnessing the evolving CRISPR/Cas9 for precision oncology
Tianye Li, Shuiquan Li, Yue Kang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Tianye Li, Shuiquan Li, Yue Kang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Base editing screens define the genetic landscape of cancer drug resistance mechanisms
Matthew A. Coelho, Magdalena E. Strauß, Alex Watterson, et al.
Nature Genetics (2024) Vol. 56, Iss. 11, pp. 2479-2492
Open Access | Times Cited: 10
Matthew A. Coelho, Magdalena E. Strauß, Alex Watterson, et al.
Nature Genetics (2024) Vol. 56, Iss. 11, pp. 2479-2492
Open Access | Times Cited: 10
scSNV-seq: high-throughput phenotyping of single nucleotide variants by coupled single-cell genotyping and transcriptomics
Sarah Cooper, Matthew A. Coelho, Magdalena E. Strauß, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Sarah Cooper, Matthew A. Coelho, Magdalena E. Strauß, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies
Yi Du, Yang Yang, Bohao Zheng, et al.
Oncogene (2025)
Open Access | Times Cited: 1
Yi Du, Yang Yang, Bohao Zheng, et al.
Oncogene (2025)
Open Access | Times Cited: 1
High-throughput screening of human genetic variants by pooled prime editing
Michael Herger, Christina M. Kajba, Megan Buckley, et al.
Cell Genomics (2025), pp. 100814-100814
Open Access | Times Cited: 1
Michael Herger, Christina M. Kajba, Megan Buckley, et al.
Cell Genomics (2025), pp. 100814-100814
Open Access | Times Cited: 1
Base editor screens for in situ mutational scanning at scale
Nicholas Z. Lue, Brian B. Liau
Molecular Cell (2023) Vol. 83, Iss. 13, pp. 2167-2187
Open Access | Times Cited: 20
Nicholas Z. Lue, Brian B. Liau
Molecular Cell (2023) Vol. 83, Iss. 13, pp. 2167-2187
Open Access | Times Cited: 20
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens
Zachary Walsh, Parin Shah, Neeharika Kothapalli, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 7
Zachary Walsh, Parin Shah, Neeharika Kothapalli, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 7
Anlotinib potentiates anti‐PD1 immunotherapy via transferrin receptor‐dependent CD8+ T‐cell infiltration in hepatocellular carcinoma
Fei Song, Bo Hu, Xiao‐Liang Liang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 7
Fei Song, Bo Hu, Xiao‐Liang Liang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 7
Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling
Mirunalini Ravichandran, Danilo Maddalo
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 15
Mirunalini Ravichandran, Danilo Maddalo
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 15
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 5
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 5
CRISPR/Cas9 screening: unraveling cancer immunotherapy’s ‘Rosetta Stone’
Baoxiang Chen, Yanrong Deng, Xianghai Ren, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 736-749
Open Access | Times Cited: 5
Baoxiang Chen, Yanrong Deng, Xianghai Ren, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 736-749
Open Access | Times Cited: 5
Accelerated drug-resistant variant discovery with an enhanced, scalable mutagenic base editor platform
Kristel M. Dorighi, Anqi Zhu, Jean‐Philippe Fortin, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114313-114313
Open Access | Times Cited: 5
Kristel M. Dorighi, Anqi Zhu, Jean‐Philippe Fortin, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114313-114313
Open Access | Times Cited: 5
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 5
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 5
Synthetic lethal strategies for the development of cancer therapeutics
Natalie Ngoi, David Gallo, C. Sevillano, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 5
Natalie Ngoi, David Gallo, C. Sevillano, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 5
CRISPR applications in cancer diagnosis and treatment
Mingxia Wang, Menghui Chen, Xia Wu, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Mingxia Wang, Menghui Chen, Xia Wu, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Health research in the era of artificial intelligence: Advances in gene-editing study
Mengyao Dai, Xiangyang Li, Qí Zhāng, et al.
Medicine Plus (2024) Vol. 1, Iss. 2, pp. 100027-100027
Open Access | Times Cited: 4
Mengyao Dai, Xiangyang Li, Qí Zhāng, et al.
Medicine Plus (2024) Vol. 1, Iss. 2, pp. 100027-100027
Open Access | Times Cited: 4
Analyzing the functional effects of DNA variants with gene editing
Sarah Cooper, Sofia Obolenski, Andrew Waters, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 5, pp. 100776-100776
Open Access | Times Cited: 4
Sarah Cooper, Sofia Obolenski, Andrew Waters, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 5, pp. 100776-100776
Open Access | Times Cited: 4
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 4
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 4
Multiplexed in vivo base editing identifies functional gene-variant-context interactions
Jonuelle Acosta, Grace A. Johnson, Samuel I. Gould, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Jonuelle Acosta, Grace A. Johnson, Samuel I. Gould, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access